- Tytuł:
- Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.
- Autorzy:
- Temat:
-
BEVACIZUMAB
ATEZOLIZUMAB
TERMINATION of treatment
PROTHROMBIN
IMMUNE checkpoint inhibitors - Źródło:
- JGH Open; Jul2023, Vol. 7 Issue 7, p476-481, 6p
Czasopismo naukowe